[go: up one dir, main page]

ImObersteg, 2018 - Google Patents

Forensic Drug Testing

ImObersteg, 2018

View PDF
Document ID
5944832253691897679
Author
ImObersteg A
Publication year
Publication venue
Drug Injury: Liability, Analysis and Prevention. Lawyers&Judges Publishing Company

External Links

Snippet

Forensic Drug Testing Page 1 Chapter 43 Forensic Drug Testing Anne D. ImObersteg, MS, JD, MBA, BA 771 Synopsis 43.1 Introduction 43.2 The Screening Test 43.3 Extraction of the Drug from the Biological Matrix 43.4 The Instruments A. GC/MS B. Quantifying a drug using the …
Continue reading at www.360exhibithall.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires

Similar Documents

Publication Publication Date Title
Mieczkowski et al. Concordance of three measures of cocaine use in an arrestee population: hair, urine, and self-report
Wish et al. Drug testing by the criminal justice system: Methods, research, and applications
US20180328950A1 (en) Method and device for monitoring medication usage
Magura et al. Validity of self-reported drug use in high risk populations: a meta-analytical review
Visher A comparison of urinalysis technologies for drug testing in criminal justice
Jones et al. Driving under the influence of psychoactive substances: A historical review
Jenkins Forensic drug testing
Dubowski Drug-Use Testing: Scientific Perspectives
Seo et al. Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair
MD et al. Postmortem toxicology of abused drugs
Christophersen et al. Drug analysis for control purposes in forensic toxicology, workplace testing, sports medicine and related areas
ImObersteg Forensic Drug Testing
Scendoni Salivary analysis for medico-legal and forensic toxicological purposes
Flanagan et al. Analytical toxicology
Dalen et al. Workplace drug testing (WDT) likely to increase in Europe: report from the First European Symposium on WDT including selected abstracts
Hearn et al. Introduction to postmortem toxicology
Auerbach Drug testing methods
Savage et al. Suitability of SoToxa® oral fluid screening over time: re-examination of drugged driving in Wisconsin
Peat Workplace drug testing
Gerostamoulos Post-Mortem Toxicology
O'Donnell et al. Forensic Drug Testing
Lewis Drug Detection and its Role in Law Enforcement.
Jacobs et al. Drug testing and the DSM-IV
Schreiber An Introduction to Testing for Drugs of Abuse
Jones et al. Driving Under the Influence of Psychoactive Substances